
Medifill
Advanced cyanoacrylate solutions for fast, safe, and effective wound closure in emergency settings.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Acquisition | |
Total Funding | 000k |
Related Content
CutisSeal specializes in advanced cyanoacrylate technology tailored for the wound closure market, focusing on providing fast, safe, and effective solutions. The company's products, such as CutisSeal Topical B, are designed for use in emergency rooms, offering a quick and safe method to close easily opposable, tension-free wounds. The formulation provides a high-strength bond with quick drying time and serves as an effective antimicrobial barrier. CutisSeal's business model revolves around supplying healthcare facilities with precision applicators that ensure flexibility and comfort during the healing process. The company generates revenue by selling these specialized wound closure products to medical institutions, particularly those operating in high-pressure environments like emergency rooms. Keywords: cyanoacrylate, wound closure, emergency room, antimicrobial, precision applicator, healthcare, medical, fast drying, high strength, flexibility.